This company listing is no longer active
HHI Stock Overview
Health House International Limited distributes medicinal cannabis products in Australasia, the United Kingdom, and Europe. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Health House International Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$0.005 |
52 Week High | AU$0.018 |
52 Week Low | AU$0.004 |
Beta | 0.40 |
11 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | -61.54% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 25.00% |
Recent News & Updates
Recent updates
Shareholder Returns
HHI | AU Healthcare | AU Market | |
---|---|---|---|
7D | 0% | -4.5% | -0.07% |
1Y | -61.5% | -3.1% | 16.9% |
Return vs Industry: HHI underperformed the Australian Healthcare industry which returned -12.7% over the past year.
Return vs Market: HHI underperformed the Australian Market which returned -0.9% over the past year.
Price Volatility
HHI volatility | |
---|---|
HHI Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 4.8% |
Market Average Movement | 8.5% |
10% most volatile stocks in AU Market | 17.0% |
10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: HHI's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine HHI's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2011 | n/a | n/a | healthhouse.com.au |
Health House International Limited distributes medicinal cannabis products in Australasia, the United Kingdom, and Europe. It supplies a range of pharmaceutical products to pharmacies, hospitals, government departments, ambulance workers, and other wholesalers. The company was formerly known as Health House Holdings Limited and changed its name to Health House International Limited in March 2021.
Health House International Limited Fundamentals Summary
HHI fundamental statistics | |
---|---|
Market cap | AU$891.12k |
Earnings (TTM) | -AU$16.10m |
Revenue (TTM) | AU$19.26m |
0.0x
P/S Ratio-0.1x
P/E RatioIs HHI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
HHI income statement (TTM) | |
---|---|
Revenue | AU$19.26m |
Cost of Revenue | AU$15.33m |
Gross Profit | AU$3.93m |
Other Expenses | AU$20.02m |
Earnings | -AU$16.10m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | -0.09 |
Gross Margin | 20.39% |
Net Profit Margin | -83.59% |
Debt/Equity Ratio | -165.3% |
How did HHI perform over the long term?
See historical performance and comparison